Can You Stop and Restart Weight Loss Injections? What Patients Need to Know

Pausing a weight loss injection is far more common than many people assume. Life gets in the way, whether that is the cost of treatment, side effects, a holiday, a house move, or simply reaching a point where you want a break. If you have stopped, or are thinking about it, you may also be wondering how to pick treatment back up safely, and finding it hard to get clear guidance on doing so.

This article offers clinician-led guidance for anyone considering a break from Mounjaro or Wegovy, or already on one. It covers why people pause, what tends to happen to your weight during a break, whether stopping suddenly is safe, and how restarting and dose titration work when you are ready to resume. As with any prescription treatment, the specifics of your own situation are best discussed with a clinician, but this gives you a solid, honest starting point.

Why do people stop taking Mounjaro or Wegovy?

There are many reasons someone might pause GLP-1 treatment, and none of them reflect a lack of commitment. Cost is one of the most common: these are long-term treatments, and the monthly expense can become difficult to sustain, particularly at higher doses. Side effects, most often gastrointestinal ones such as nausea, can also prompt a break, especially if they have not settled.

For others, the reason is more positive: some people reach a goal weight and want to see how they manage without medication. And sometimes life simply intervenes, whether that is travel, pregnancy planning, surgery, or a period when weekly injections are not practical.

Whatever the reason, pausing treatment is common and does not mean you have failed. It is best to discuss stopping with a clinician rather than stopping abruptly, particularly if you are on a higher maintenance dose, so that you know what to expect and how to resume safely if you choose to.

What happens to your weight when you stop treatment?

GLP-1 medications work by reducing appetite, slowing how quickly the stomach empties, and quietening the background "food noise" that can make eating hard to manage. Once the medication is stopped, these effects gradually wear off, and appetite and hunger signals tend to return towards their pre-treatment levels. [3][4]

As a result, some degree of weight regains after stopping is common, and this is well documented. In the STEP 1 trial extension, participants regained on average around two-thirds of the weight they had lost in the year after stopping semaglutide and the accompanying lifestyle support. [1] A similar pattern was seen with tirzepatide in the SURMOUNT-4 trial: people who stopped regained a substantial proportion of their lost weight, while those who continued maintained their results. [2]

It is important to understand that this is a normal physiological response, not a personal failing. It reflects the fact that obesity is a chronic condition, much like high blood pressure or high cholesterol, where stopping treatment tends to reverse the benefit. [1] The habits built during treatment, such as more mindful eating patterns and regular activity, can help slow or reduce regain, which is why they are worth maintaining whether or not you stay on medication. This rebound reflects the way GLP-1 injections work: their effect on appetite fades once the medication leaves your system.

     One of the most important messages I try to give patients is that weight regain after stopping treatment is a biological response, not a personal failure. Obesity is a chronic, relapsing condition. When medication is stopped, the hormonal signals that regulate hunger and fullness can return towards their previous state, making it much harder to maintain weight loss. This isn't about a lack of willpower—it's about physiology. That's why, for many people, obesity should be managed as a long-term medical condition, just like high blood pressure or asthma, with an individualised plan for ongoing treatment and support."

— Dr Saira Bano, GP & Co-Founder, SwiftDoctor

Is it safe to stop Mounjaro or Wegovy suddenly?

From a purely medical standpoint, stopping a GLP-1 medication is generally considered safe. Unlike some medicines, these treatments do not need to be tapered off for safety reasons, as they are not associated with a physical withdrawal syndrome. [3][4] The main consequence of stopping is the gradual return of appetite and, over time, the potential for weight regain described above. Patients on higher maintenance doses may notice appetite returning more quickly than those on lower doses, simply because the effect being withdrawn is greater.

Coming off more gradually where possible can help you manage the transition. And if you have any underlying health conditions, or take other medications such as those for type 2 diabetes, it is particularly important to discuss stopping with a clinician first, so they can advise on timing, what to monitor, and how to approach a break in a way that suits your circumstances.

Can you restart Mounjaro or Wegovy after a break?

Yes. Restarting treatment after a break is both possible and common, and many people move in and out of treatment over the course of their weight management journey. Neither Mounjaro nor Wegovy becomes less effective simply because you have paused, and there is no reason a well-managed break should prevent you from benefiting again.

The main factor affecting how treatment is restarted is the length of the break. A short pause is often straightforward to resume, whereas a longer gap usually means your body needs to readjust to the medication, which has implications for tolerability and dosing, covered in the next section.

Before restarting, a clinician will review your current health status and treatment history, much as they would before starting for the first time, to confirm you still meet the eligibility criteria for treatment.

How does dosing work when restarting after a break?

The right approach to dosing on restart depends largely on how long you have been off treatment. After a longer break, patients are usually advised to restart at a lower dose and re-titrate upwards gradually, much like starting treatment for the first time. This is because tolerance to the medication’s effect on the stomach reduces during a break, and stepping the dose back up slowly helps limit side effects such as nausea. The Wegovy product information, for example, advises that if two or more consecutive doses are missed, treatment may need to be reinitiated at a lower dose and re-escalated. [4]

After a shorter break, it may be possible to resume at or near your previous dose, depending on how you tolerated it before and your clinician’s judgement. [3][4] There is no single rule that fits everyone, which is exactly why these decisions should always be made with a clinician rather than self-adjusted. Restarting at too high a dose after a gap is one of the more common causes of avoidable side effects.

     "Whether you can restart at your previous dose depends largely on how long you've been off treatment. A short break may mean it's appropriate to continue on the same dose, whereas a longer break may require re-titration to reduce the risk of side effects such as nausea, vomiting and gastrointestinal upset. There isn't a one-size-fits-all answer, which is why it's important to seek advice from a clinician rather than deciding yourself. We assess each patient individually to ensure they restart treatment as safely and effectively as possible."

— Dr Saira Bano, GP & Co-Founder, SwiftDoctor

What is a maintenance dose and how does it fit into long-term use?

A maintenance dose is the dose you settle on once you have either reached your treatment goal or arrived at a stable, well-tolerated level that continues to support your progress. Rather than continually increasing the dose, the aim at this stage is to sustain results on the lowest dose that works well for you. [3][4]

Because obesity is a chronic condition, some patients remain on a maintenance dose over the long term to hold onto the improvements they have made, in the same way that treatment for other long-term conditions is often ongoing. [1] Others, under clinical guidance, taper down or take planned breaks. There is no universally "right" answer; the best approach depends on your goals, response and health profile.

What matters most is that long-term use, including maintenance dosing, is reviewed regularly with a clinician rather than left to run indefinitely. You can find out more about our approach on our maintenance page.

How SwiftDoctor supports patients through breaks and restarts

SwiftDoctor is a doctor-led service, and our clinicians support you through the whole of your treatment journey, including pausing, stopping and restarting safely. Whether you need a break for cost, side effects or personal reasons, this is treated as a normal part of long-term weight management rather than something to feel awkward about.

Our care does not stop at a single prescription. Ongoing check-ins and dose reviews are built into the service, which means you have clinical support on hand when you are deciding whether to pause, and again when you are ready to resume at the right dose for you. The approach is personalised and judgement-free. If you would like to explore your options, you can find out more about our weight loss treatments.

Frequently asked questions

Will I regain all the weight if I stop Mounjaro or Wegovy?

Not necessarily, but some regain is common. Trials show people tend to regain a meaningful proportion of lost weight after stopping, on average around two-thirds within a year with semaglutide, because appetite returns once the medication is withdrawn. [1] Not everyone regains everything, and the habits you build during treatment can help. This is a physiological response, not a failure of willpower.

How long can you take a break from Mounjaro before restarting at a lower dose?

There is no fixed cut-off; it is based on clinical judgement rather than a set number of weeks. As a general principle, longer breaks are more likely to require restarting at a lower dose and re-titrating, while shorter gaps may allow resumption at or near your previous dose. [3][4] Your clinician will advise based on how long you have been off treatment and how you tolerated it.

Is it dangerous to stop weight loss injections suddenly?

Stopping is generally considered safe, and GLP-1 medications are not associated with dangerous withdrawal effects. [3][4] The main consequence is the gradual return of appetite and the potential for weight regain over time. If you have underlying health conditions or take other medications, it is still worth discussing stopping with a clinician first.

Can you restart Mounjaro or Wegovy at the same dose you were on before?

Sometimes, but not always. After a short break you may be able to resume at or close to your previous dose, whereas after a longer gap restarting lower and building back up is usually safer for tolerability. [3][4] This should be decided with a clinician rather than self-managed, as restarting too high after a break is a common cause of avoidable nausea.

How long can you stay on a GLP-1 maintenance dose?

There is no set time limit and at SwiftDoctor we support life long maintenance. Because obesity is a chronic condition, many people stay on a maintenance dose long term to sustain results, with treatment reviewed regularly by a clinician. [1] Others taper down or take breaks under guidance. The right duration depends on your individual goals, response and health circumstances.

Sources

[1] Wilding JPH et al., Diabetes, Obesity and Metabolism, "Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension", https://doi.org/10.1111/dom.14725

[2] Aronne LJ et al., JAMA, "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial", https://doi.org/10.1001/jama.2023.24945

[3] Electronic Medicines Compendium (eMC), "Mounjaro 2.5 mg solution for injection: Summary of Product Characteristics" (Eli Lilly), https://www.medicines.org.uk/emc/product/15484/smpc

[4] Electronic Medicines Compendium (eMC), "Wegovy 0.25 mg–2.4 mg solution for injection: Summary of Product Characteristics" (Novo Nordisk), https://www.medicines.org.uk/emc/product/13616/smpc